Cita APA (7a ed.)

MZ, H., SH, A. A., Z, Z., & MN, H. (2011). Development of antiproliferative nanohybrid compound with controlled release property using ellagic acid as the active agent. Dove Medical Press.

Cita Chicago Style (17a ed.)

MZ, Hussein, Al Ali SH, Zainal Z, y Hakim MN. Development of Antiproliferative Nanohybrid Compound with Controlled Release Property Using Ellagic Acid as the Active Agent. Dove Medical Press, 2011.

Cita MLA (8a ed.)

MZ, Hussein, et al. Development of Antiproliferative Nanohybrid Compound with Controlled Release Property Using Ellagic Acid as the Active Agent. Dove Medical Press, 2011.

Precaución: Estas citas no son 100% exactas.